In Vivo IL-12 Administration Induces Profound but Transient Commitment to T Helper Cell Type 1-Associated Patterns of Cytokine and Antibody Production

Journal of Immunology

Volumn 159, Issue 3, 1997, Pages 1490-1496

  Rempel, Julia D ^a   Wang, MingDong ^a   HayGlass, Kent T ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITOPE; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; OVALBUMIN; RECOMBINANT PROTEIN;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MOUSE; PASSIVE IMMUNIZATION; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; EPITOPES; IMMUNIZATION, PASSIVE; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; MICE; MICE, INBRED C57BL; OVALBUMIN; RECOMBINANT PROTEINS; TH1 CELLS;

EID: 0031202698     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
2. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
3. Trinchieri, O. 1995. Interleukin-12: a proinflammatory cytokine with immuno-regulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
4. Wenner, C. A., M. L. Güler, S. E. Macatonia, A. O'Garra, and K. M. Murphy. 1996. Roles of IFN-γ and IFN-α in IL-12-induced T helper cell-1 development. J. Immunol. 156:1442.
5. Bradley, L. M., K. Yoshimoto, and S. L. Swain. 1995. The cytokines IL-4, IFN-γ, and IL-12 regulate the development of subsets of memory effector helper T cells in vitro. J. Immunol. 155:1713.
6. + T cells through an effect on antigen-presenting cells. J. Immunol. 154:2578.
7. Scott, P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science 260:496.
8. Hall, S. S. 1995. IL-12 at the crossroads. Science 268:1432.
9. Wynn, T. A., A. W. Cheever, D. Jankovic, R. W. Poindexter, P. Casper, F. A. Lewis, and A. Sher. 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376:594.
10. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Anna. Rev. Immunol. 12:227.
11. Holt, P. G. 1994. Immunoprophylaxis of atopy: light at the end of the tunnel? Immunol. Today 15:484.
12. Yang, X., and K. T. HayGlass. 1994. Allergen dependent induction of interleukin 4 synthesis in vivo. Immunology 78:74.
13. Gieni, R. S., X. Yang, and K. T. HayGlass. 1993. Allergen-specific modulation of cytokine synthesis patterns and IgE responses in vivo with chemically modified allergen. J. Immunol. 150:302.
14. Koo, G. C., F. J. Dumont, M. Tutt, J. Hackett, Jr., and V. Kumar. 1986. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells. J. Immunol. 137:3742.
15. HayGlass, K. T., and B. P. Stefura. 1991. Anti-interferon γ treatment blocks the ability of glutaraldehyde-polymerized allergens to inhibit specific IgE responses. J. Exp. Med. 173:279.
16. Yang, X., R. Gieni, T. R. Mosmann, and K. T. HayGlass. 1993. Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo. J. Exp. Med. 178:349.
17. Germann, T., M. K. Gately, D. S. Schoenhaut, M. Lohoff, F. Mattner, S. Fischer, S.-C. Jin, E. Schmitt, and E. Rude. 1993. Interleukin-12/T cell simulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not Th2 cells. Eur. J. Immunol. 23:1762.
18. + T cells. Eur. J. Immunol. 24:343.
19. McKnight, A. J., G. J. Zimmer, I. Fogelman, S. F. Wolf, and A. K. Abbas. 1994. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152:2172.
20. Bree, A. G., F. J. Schlerman, M. D. Kaviani, R. C. Hastings, S. L. Hitz, and S. J. Goldman. 1994. Multiple effects on peripheral hematology following administration of recombinant human interleukin 12 to nonhuman primates. Biochem. Biophys. Res. Commun. 204:1150.
21. Dybedal, I., S. Larsen, and S. E. W. Jacobsen. 1995. IL-12 directly enhances in vitro murine erythropoiesis in combination with IL-4 and stem cell factor. J. Immunol. 154:4950.
22. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115.
23. Khan, I. A., T. Matsuura, and L. H. Kasper. 1994. Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect. Immun. 62:1639.
24. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin 12 induction of interferon γ-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91:10700.
25. Pearlman, E., F. P. Heinzel, F. E. Hazlett, Jr., and J. W. Kazura. 1995. IL-12 modulation of T helper responses to the filarial helminth, Brugia malayi. J. Immunol. 154:4658.
26. Urban, J. F., Jr., R. Fayer, S.-J. Chen, W. C. Gause, M. K. Gately, and F. D. Finkelman. 1996. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J. Immunol. 156:263.
27. Schijns, V. E. C. J., B. L. Haagmans and M. C. Horzinek. 1995. IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-γ-receptor-deficient mice. J. Immunol. 155:2525.
28. Wynn, T. A., D. Jankovic, S. Hieny, A. W. Cheever, and A. Sher. 1995. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J. Immunol. 154:4701.
29. Gavett, S. H., D. J. O'Hearn, X. Li, S.-K. Huang, F. D. Finkelman, and M. Wills-Karp. 1995. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182:1527.
30. Zhou, P., M. C. Sieve, J. Bennett, K. J. Kwon-Chung, R. P. Tewari, R. T. Gazzinelli, A. Sher, and R. A. Seder. 1995. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ. J. Immunol. 155:785.
31. Yanagida, T., T. Kato, O. Igarashi, T. Inoue, and H. Nariuchi. 1994. Second signal activity of IL-12 on the proliferation and IL-2R expression of T helper cell-1 clone. J. Immunol. 152:4919.
32. Kennedy, M. K., K. S. Picha, K. D. Shanebeck, D. M. Anderson, and K. H. Grabstein. 1994. Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones. Eur. J. Immunol. 24:2271.
33. Bertagnolli, M. M., B.-Y. Lin, D. Young, and S. H. Herrmann. 1992. IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J. Immunol. 149:3778.
34. Morris, S. C., K. B. Madden, J. J. Adamovicz, W. C. Gause, B. R. Hubbard, M. K. Gately, and F. D. Finkelman. 1994. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152:1047.
35. Bliss, J., V. V. Cleave, K. Murray, A. Wiencis, M. Ketchum, R. Maylor, T. Haire, C. Resmini, A. K. Abbas, and S. F. Wolf. 1996. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J. Immunol. 156:887.
36. Orange, J. S., T. P. Salazar-Mather, S. M. Opal, R. L. Spencer, A. H. Miller, B. S. McEwen, and C. A. Biron. 1995. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:901.
37. Eng, V. M., B. D. Car, B. Schnyder, M. Lorenz, S. Lugli, M. Aguet, T. D. Anderson, B. Ryffel, and V. F. J. Quesniaux. 1995. The stimulatory effects of interleukin (IL)-12 on hematopoiesis are antagonized by IL-12-induced interferon γ in vivo. J. Exp. Med. 181:1893.
38. Manetti, R., P. Parronchi, M. G. Giudizi, M.-P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin-12 (IL-12)) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199.
39. + allergen-specific Th2 T cell clones. Int. Immunol. 6:1091.
40. Kiniwa, M., M. K. Gately, U. Gubler, R. Chizzonite, C. Fargeas, and G. Delespesse. 1992. Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J. Clin. Invest. 90:262.
41. Germann, T., S. Guckes, M. Bongartz, H. Dlugonska, E. Schmitt, L. Kolbe, E. Kölsch, F. J. Podlaski, M. K. Gately, and E. Rüde. 1995. Administration of IL-12 during ongoing immune responses fails to permanently suppress and can even enhance the synthesis of antigen-specific IgE. Int. Immunol. 7:1649.
42. Oswald, I. P., P. Caspar, D. Jankovic, T. A. Wynn, E. J. Pearce, and A. Sher. 1994. IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni. J. Immunol. 153:1707.
43. Tripp, C. S., S. F. Wolf, and E. R. Unanue. 1993. Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90:3725.
44. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
45. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797.
46. Afonso, L. C. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235.
47. Hoffman, S. L., J. M. Crutcher, S. K. Puri, A. A. Ansari, F. Villinger, E. D. Franke, P. P. Singh, F. Finkelman, M. K. Gately, F. P. Dutta, and M. Sedegah. 1997. Sterile protection of monkeys against malaria after administration of interleukin 12. Nat. Med. 3:80.
48. Marinaro, M., P. N. Boyaka, F. D. Finkelman, H. Kinoyo, R. J. Jackson, E. Jirillo, and J. R. McGhee. 1997. Oral but not parenteral IL-12 redirects T helper 2 responses to an oral vaccine without altering mucosal IgA responses. J. Exp. Med. 185:415.
49. Kim, J. J., V. Ayyavoo, M. L. Bagarazzi, M. A. Chattergoon, K. Dang, B. Wang, J. D. Boyer, and D. B. Weiner. 1997. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:816.